France· FR:61066196
ALUNBRIG 90 mg + 180 mg, comprimé pelliculé
A medicinal product containing brigatinib, registered in France by TAKEDA PHARMA (DANEMARK), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BRIGATINIB
- Manufacturer
- TAKEDA PHARMA (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930171950Plaquette thermoformée (ACLAR RX) polytrifluorochloroéthylène aluminium de 7 comprimés + plaquettes thermoformées ACLAR RX) polytrifluorochloroéthylène aluminium de 21 comprimés (Kit d’initiation de 28 comprimés)EUR 3.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brigatinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALUNBRIGTakeda Pharma A/S, Vallensbaek Strand
- SwitzerlandAlunbrig
- NorwayAlunbrigTakeda Pharma A/S (1)
- SpainALUNBRIG 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULATakeda Pharma A/S
- SwedenAlunbrig 90 mg + 180 mg Filmdragerad tablettTakeda Pharma A/S
- BelgiumAlunbrig 90 mgTakeda Pharma
- PolandAlunbrigTakeda Pharma A/S
- United StatesAlunbrigTakeda Pharmaceuticals America, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alunbrig
- Liechtenstein · Alunbrig
- Norway · Alunbrig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff1aacaa-c404-4594-9453-e5ce5446795e GET /v1/drugs/ff1aacaa-c404-4594-9453-e5ce5446795e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61066196",
"date_amm": "2019-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/18/1264",
"substance": "BRIGATINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about brigatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.